These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22751954)

  • 1. Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies?
    Köhne A; Stettner M; Jangouk P; Dehmel T; Hartung HP; Lehmann HC; Kieseier BC
    Arch Neurol; 2012 Oct; 69(10):1280-9. PubMed ID: 22751954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
    Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP
    Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions.
    Van Doorn R; Van Horssen J; Verzijl D; Witte M; Ronken E; Van Het Hof B; Lakeman K; Dijkstra CD; Van Der Valk P; Reijerkerk A; Alewijnse AE; Peters SL; De Vries HE
    Glia; 2010 Sep; 58(12):1465-76. PubMed ID: 20648639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.
    Mullershausen F; Craveiro LM; Shin Y; Cortes-Cros M; Bassilana F; Osinde M; Wishart WL; Guerini D; Thallmair M; Schwab ME; Sivasankaran R; Seuwen K; Dev KK
    J Neurochem; 2007 Aug; 102(4):1151-61. PubMed ID: 17488279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.
    Osinde M; Mullershausen F; Dev KK
    Neuropharmacology; 2007 Apr; 52(5):1210-8. PubMed ID: 17379261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
    Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S
    Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
    Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.
    Dev KK; Mullershausen F; Mattes H; Kuhn RR; Bilbe G; Hoyer D; Mir A
    Pharmacol Ther; 2008 Jan; 117(1):77-93. PubMed ID: 17961662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
    Lee CW; Choi JW; Chun J
    Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2.
    Yoshino T; Tabunoki H; Sugiyama S; Ishii K; Kim SU; Satoh J
    Cell Mol Neurobiol; 2011 Oct; 31(7):1009-20. PubMed ID: 21519925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
    Brinkmann V
    Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination.
    Kipp M; Amor S
    Mult Scler; 2012 Mar; 18(3):258-63. PubMed ID: 22383435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod phosphate promotes the neuroprotective effects of microglia.
    Noda H; Takeuchi H; Mizuno T; Suzumura A
    J Neuroimmunol; 2013 Mar; 256(1-2):13-8. PubMed ID: 23290828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V; Chwalla I; Siess W
    Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro.
    Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Huang Y
    Int J Mol Med; 2012 Jul; 30(1):211-9. PubMed ID: 22576630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
    Chiba K; Adachi K
    Future Med Chem; 2012 Apr; 4(6):771-81. PubMed ID: 22530640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
    Heinen A; Beyer F; Tzekova N; Hartung HP; Küry P
    Exp Neurol; 2015 Sep; 271():25-35. PubMed ID: 25957629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination.
    Liang G; Cline GW; Macica CM
    Glia; 2007 Apr; 55(6):632-41. PubMed ID: 17299765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
    Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
    Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.